Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BF.B Brown Forman Corp
- Stocks
- Consumer Defensive
- NYSE: BF.B
Price (delayed)
$35.28
Market cap
$16.68B
P/E Ratio
16.88
Dividend/share
$0.89
EPS
$2.09
Enterprise value
$18.94B
The Brown–Forman Corporation is one of the largest American-owned companies in the spirits and wine business. Based in Louisville, Kentucky, it manufactures several well known brands throughout the world, including
Highlights
The stock's price to earnings (P/E) is 51% less than its 5-year quarterly average of 34.8 and 16% less than its last 4 quarters average of 20.2
BF.B's quick ratio is up by 35% since the previous quarter and by 31% year-on-year
The company's gross profit fell by 7% YoY
Brown Forman's revenue has decreased by 5% YoY
Sector: Consumer Defensive
Industry: Beverages - Wineries & Distilleries
Website: https://www.brown-forman.com/
Key stats
What are the main financial stats of BF.B
Market
Valuations
Earnings
Shares outstanding
472.67M
Market cap
$16.68B
Enterprise value
$18.94B
Price to earnings (P/E)
16.88
Price to book (P/B)
4.36
Price to sales (P/S)
4.12
EV/EBIT
13.78
EV/EBITDA
12.96
EV/Sales
4.68
Revenue
$4.05B
Gross profit
$2.4B
Operating income
$1.36B
Net income
$989M
EBIT
$1.37B
EBITDA
$1.46B
Free cash flow
$572M
Per share
Balance sheet
Liquidity
EPS
$2.09
EPS diluted
$2.09
Free cash flow per share
$1.21
Book value per share
$8.09
Revenue per share
$8.56
TBVPS
$11.98
Total assets
$8.07B
Total liabilities
$4.25B
Debt
$2.86B
Equity
$3.82B
Working capital
$3.05B
Debt to equity
0.75
Current ratio
3.49
Quick ratio
1.19
Net debt/EBITDA
1.55
Margins
Efficiency
Dividend
EBITDA margin
36.1%
Gross margin
59.3%
Net margin
24.4%
Operating margin
33.6%
Return on assets
12.1%
Return on equity
27.3%
Return on invested capital
20%
Return on capital employed
20.1%
Return on sales
34%
Dividend yield
2.52%
DPS
$0.89
Payout ratio
42.5%
BF.B stock price
How has the Brown Forman stock price performed over time
Intraday
1.79%
1 week
2.56%
1 month
2.83%
1 year
-28.18%
YTD
-7.11%
QTD
3.95%
Financial performance
How have Brown Forman's revenue and profit performed over time
Revenue
$4.05B
Gross profit
$2.4B
Operating income
$1.36B
Net income
$989M
Gross margin
59.3%
Net margin
24.4%
The operating margin has grown by 15% YoY
The operating income has grown by 9% YoY
The net margin has grown by 7% YoY
The company's gross profit fell by 7% YoY
Price vs fundamentals
How does BF.B's price correlate with its fundamentals
Growth
What is Brown Forman's growth rate over time
Valuation
What is Brown Forman stock price valuation
P/E
16.88
P/B
4.36
P/S
4.12
EV/EBIT
13.78
EV/EBITDA
12.96
EV/Sales
4.68
The stock's price to earnings (P/E) is 51% less than its 5-year quarterly average of 34.8 and 16% less than its last 4 quarters average of 20.2
The company's EPS rose by 4% YoY
BF.B's P/B is 58% below its 5-year quarterly average of 10.4 and 22% below its last 4 quarters average of 5.6
The equity has grown by 18% YoY and by 3.2% from the previous quarter
The P/S is 47% below the 5-year quarterly average of 7.8 and 16% below the last 4 quarters average of 4.9
Brown Forman's revenue has decreased by 5% YoY
Efficiency
How efficient is Brown Forman business performance
The company's return on sales rose by 8% YoY
The company's return on equity fell by 6% YoY and by 5% QoQ
BF.B's return on invested capital is up by 3.1% year-on-year
Dividends
What is BF.B's dividend history
DPS
$0.89
Dividend yield
2.52%
Payout ratio
42.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Brown Forman financials performed over time
The company's total assets is 90% higher than its total liabilities
BF.B's quick ratio is up by 35% since the previous quarter and by 31% year-on-year
The current ratio has increased by 29% QoQ and by 27% YoY
The debt is 25% less than the equity
The debt to equity has contracted by 29% YoY and by 13% from the previous quarter
The equity has grown by 18% YoY and by 3.2% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.